< Back to search
Filter
1

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

for
Non-Hodgkin's Lymphoma, Hodgkin's Disease,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT00131014

Recruiting

Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL

for
Lymphoma, Primary Central Nervous System Lymphoma
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06475235

Phase1, Recruiting

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

for
Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma,
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06508463

Phase1, Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma,
Location: Columbus OH, Sioux Falls SD, Orange CA, Eugene OR
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT01804686

Phase3, Recruiting

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

for
B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 60+

Code: NCT06052826

Phase2, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

for
Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT06227026

Phase1, Recruiting

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

for
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Charlotte NC, Memphis TN, Tulsa OK
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 1 - 18

Code: NCT06533748

Phase2, Recruiting

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

for
Hematologic Malignancy, Bone Marrow Transplant Rejection,
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT06398457

Early_phase1, Recruiting

LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

for
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18 - 70+

Code: NCT05990465

Phase1, Recruiting

Living Well With Lymphoma

for
Lymphoma
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT06047626

Recruiting

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

for
Relapsed/Refractory Follicular Lymphoma,
Location: Lebanon NH, Stony Brook NY, Plantation FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06149286

Phase3, Recruiting

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

for
Relapsed/Refractory Non-Hodgkin Lymphoma
Location: Boston MA, New York NY, Tampa FL, Rochester MN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06090539

Phase1, Phase2, Recruiting

Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma

for
Double-Expressor Lymphoma,
Location: San Diego CA, Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT05600686

Phase2, Recruiting

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

for
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia,
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18 - 70+

Code: NCT01890486

Recruiting

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

for
Acute Leukemia, Acute Myeloid Leukemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 60

Code: NCT03314974

Phase2, Recruiting

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

for
B-Cell Non-Hodgkin Lymphoma,
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT03017820

Phase1, Recruiting

Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors

for
Atrial Fibrillation, Supraventricular Arrhythmia,
Location: New Hyde Park NY
Sponsor: Northwell Health

Sex: All

Age: 18+

Code: NCT05643235

Recruiting

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

for
Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma,
Location: Boston MA, Bronx NY, New York NY, Hackensack NJ,
Sponsor: Caribou Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04637763

Phase1, Recruiting

A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

for
Lymphoma, B-Cell, Lymphoma, T-Cell
Location: New York NY, Sarasota FL, Denver CO
Sponsor: Step Pharma, SAS

Sex: All

Age: 18+

Code: NCT05463263

Phase1, Phase2, Recruiting

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

for
Hodgkin's Disease, Non-Hodgkin's Lymphoma,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 0+

Code: NCT01555892

Phase1, Recruiting